Expression of RELL2 was associated with decreased overall survival, disease-specific survival, and/or progression-free interval for several cancers, including adenoid cystic carcinoma, kidney chromophobe (KICH), and uterine carcinosarcoma. This evidence concerns the gene RELL2 and cancer.